StockData
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. (XENE) stock

XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$37.75−1.03 (-2.66%)

Close on Nov 18, 2026Market cap $3.66BP/E –Yield –

Xenon Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Xenon Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $0, down 100.0% year over year. For fiscal 2025 it was $7.50M. Over ten years it grew -12.5% a year on average. The highest annual figure on record is $32.17M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.50M–
FY2024Dec 31, 2024$0–
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$9.43M-48.8%
FY2021Dec 31, 2021$18.44M-42.7%
FY2020Dec 31, 2020$32.17M+371.0%
FY2019Dec 31, 2019$6.83M+2095.8%
FY2017Dec 31, 2017$311.00K-82.8%
FY2016Dec 31, 2016$1.80M-88.4%
FY2015Dec 31, 2015$15.58M-45.1%
FY2014Dec 31, 2014$28.37M+3.7%
FY2013Dec 31, 2013$27.36M+91.2%
FY2012Dec 31, 2012$14.31M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0–
Q1 FY2026Mar 31, 2026$0-100.0%
Q4 FY2025Dec 31, 2025$0–
Q3 FY2025Sep 30, 2025$0–
Q2 FY2025Jun 30, 2025$0–
Q1 FY2025Mar 31, 2025$7.50M–
Q4 FY2024Dec 31, 2024$0–
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$0-100.0%
Q1 FY2024Mar 31, 2024$0-100.0%
Q4 FY2022Dec 31, 2022$0-100.0%
Q3 FY2022Sep 30, 2022$132.00K-98.4%
Q2 FY2022Jun 30, 2022$536.00K-75.8%
Q1 FY2022Mar 31, 2022$8.77M+101.1%
Q4 FY2021Dec 31, 2021$3.74M-27.4%
Q3 FY2021Sep 30, 2021$8.12M+24.0%
Q2 FY2021Jun 30, 2021$2.22M-83.4%
Q1 FY2021Mar 31, 2021$4.36M-38.4%
Q4 FY2020Dec 31, 2020$5.15M+54.7%
Q3 FY2020Sep 30, 2020$6.55M+87.3%
Q2 FY2020Jun 30, 2020$13.38M+83550.0%
Q1 FY2020Mar 31, 2020$7.08M+2581.1%
Q4 FY2019Dec 31, 2019$3.33M+22093.3%
Q3 FY2019Sep 30, 2019$3.50M+21775.0%
Q4 FY2017Dec 31, 2017$16.00K-95.7%
Q3 FY2017Sep 30, 2017$264.00K-36.1%
Q2 FY2017Jun 30, 2017$15.00K–
Q1 FY2017Mar 31, 2017$16.00K–
Q4 FY2016Dec 31, 2016$376.00K–
Q3 FY2016Sep 30, 2016$413.00K–

More Xenon Pharmaceuticals figures

See a number that looks wrong?